NEW YORK, March 31 /PRNewswire/ -- JLL Partners, a leading private equity investment fund ("JLL"), today announced the completion of its acquisition of PharmaNet Development Group, Inc...
NEW YORK, March 30 /PRNewswire/ -- JLL Partners, a leading private equity investment fund ("JLL"), today announced the successful completion of the tender offer by its affiliates, JLL PharmaNet...
New York, March 20 /PRNewswire/ -- JLL Partners, a leading private equity investment fund ("JLL"), and PharmaNet Development Group, Inc., a leading provider of clinical development services...
NEW YORK, March 18 /PRNewswire/ -- JLL Partners ("JLL"), a leading private equity investment firm, announced today that its affiliates have received approval from the German Federal Cartel...
PRINCETON, N.J., March 17 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company" , "PDGI" or "PharmaNet") (NASDAQ:PDGI), a leading provider of clinical development services...
NEW YORK, March 13 /PRNewswire/ -- JLL Partners ("JLL"), a leading private equity investment firm, announced today that it has extended the expiration date for its previously announced tender...
A New Choice in Clinical Resourcing and Talent Management PRINCETON, N.J., March 4 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company") (NASDAQ:PDGI), a leading provider...
PRINCETON, N.J., Feb. 25 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company") (NASDAQ:PDGI), a leading provider of clinical development services, today reported...
PRINCETON, N.J., Feb. 18 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company") (NASDAQ:PDGI), a leading provider of clinical development services to innovative...
NEW YORK, Feb. 12 /PRNewswire/ -- JLL Partners, a leading private equity investment fund ("JLL") and PharmaNet Development Group, Inc. ("PharmaNet") announced today that JLL PharmaNet Holdings...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.